BioNTech SE - ADR vs C.H. Robinson Worldwide, Inc. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while C.H. Robinson Worldwide, Inc. trades at $145.4 (market cap $16.96B). The key difference: BioNTech SE - ADR is the larger of the two by market cap, and C.H. Robinson Worldwide, Inc. pays a 1.74% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | CHRW | |
|---|---|---|
Market Cap | $23.31B | $16.96B |
Sector | Health | Industrials |
52-Week High | $119.34 | $209.42 |
52-Week Low | $83.89 | $118.77 |
Enterprise Value | $6.60B | $18.78B |
Dividend Yield | — | 1.74% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (57% of 2021 net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm also operates a large air and ocean forwarding division (34%), which has grown organically and via tuck-in acquisitions. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.
Read more on CHRW →